Treatment
HPV vaccine clinical trials
We’re tracking 66 recruiting studies that include HPV vaccine, each written for real people, not researchers, below.
Recruiting studies
- NCT06997705Recruiting
HPV vaccine and health check for teens in Ivory Coast
This study combines HPV vaccination with other health services for young people in Ivory Coast. It aims to protect adolescents against HPV, which can cause cancer, while also checking their overall health and well-being.
AbidjanAges 9–110 - NCT06624839RecruitingPhase 2
HPV vaccine study for people with and without HIV
This study tests how well the Gardasil 9 HPV vaccine works in people assigned male at birth, including those with HIV and those taking hormone therapy. Results could help protect against HPV-related cancers.
Washington D.C., District of ColumbiaAges 18–70 - NCT06598475Recruiting
Improving HPV vaccination in Latino teens at health centers
This trial tests a program to help community health centers recommend and boost HPV vaccination rates among Latino adolescents aged 11-12. It aims to support health care providers and staff with education and resources.
Houston, TexasAges 11–17 - NCT07248904Recruiting
HPV education study for first-year nursing students
This study tests whether a special education program based on the transtheoretical model improves nursing students' knowledge about HPV, their health beliefs, and their intentions to get vaccinated. It aims to help students make informed decisions about HPV prevention.
Adana, CUKUROVAAges 18 years+ - NCT06799494RecruitingPhase 4
HPV vaccine: testing a reduced dose schedule
This study tests if giving fewer doses of the HPV vaccine still protects against HPV-related cancers. It may help people who are willing to get a reduced number of shots.
Decatur, GeorgiaAges 18–45 - NCT06926062Recruiting
Improving HPV vaccine communication in pharmacies
This study looks at whether training pharmacy staff in communication and vaccination workflows can improve HPV vaccine recommendations and uptake. If you are a parent or guardian of a child aged 9–17 who has not yet completed the HPV vaccine series, you may be eligible to participate.
University Park, PennsylvaniaAges 18 years+ - NCT07637630Recruiting
HPV Vaccine Education for Vietnamese American Parents
This study helps parents in the Vietnamese American community learn about the HPV vaccine, which prevents certain cancers. Researchers will work with you to understand what information helps families decide about vaccinating their children.
Chicago, IllinoisAges 18 years+ - NCT04611022Recruiting
Help increase HPV vaccine completion in Denver families
This study tests an educational program to help people in Denver who have not yet started the HPV vaccine (or haven’t finished it) complete the vaccine series. It may help families understand the vaccine and follow through with completing the recommended doses.
Denver, ColoradoAges 18 years+ - NCT04588402Recruiting
Tests whether HPV vaccination prevents cervical HPV infection in young women
This study looks at whether HPV vaccination lowers the chance of getting HPV in the cervix. It will collect cervical samples and ask questions to see how vaccination affects infection in women in Sikkim, India.
Gangtok, SikkimAges 18–22 - NCT07414719Recruiting
HPV vaccine study for teens and teachers in AuRA
This study tests a program to increase HPV vaccination among teens aged 11-17 in public schools. It aims to see if education and support can help more adolescents get the vaccine to prevent HPV-related cancers.
Saint-PriestAges 11–17 - NCT06220747Recruiting
HPV vaccine study for women ages 12 to 45
This study tests how well the HPV vaccine works in women and teens. It's for those who are willing to get an HPV test and haven't already had all 3 doses of the vaccine.
Bangkok, Select...Ages 12–45 - NCT06831383Recruiting
HPV vaccine study in primary care
This study helps make sure kids get the HPV vaccine during routine checkups. It is for children who have not yet had any dose of the HPV vaccine.
Alexandria, VirginiaAges 9–17 - NCT07104240Recruiting
Improving HPV vaccination for preteens ages 9-12
This study tests a program designed to help primary care practices increase HPV vaccination rates among adolescents aged 9 to 12 who haven't yet been vaccinated. It aims to find out if providing practices with resources and support can lead to more kids getting the HPV vaccine.
Atlanta, GeorgiaAges 9 years+ - NCT05266898RecruitingPhase 4
HPV vaccine response study for people living with HIV
This trial studies how well the Gardasil-9 HPV vaccine triggers the body’s immune response in people living with HIV. It may help doctors understand the best way to protect against HPV-related cancers and infections in this population.
New Orleans, LouisianaAges 18–65 - NCT07668271RecruitingPhase 4
HPV 9-valent vaccine lot consistency trial for women
This trial tests whether different batches of the HPV 9-valent vaccine work consistently. It's for Chinese women aged 18 to 30 who have not had any HPV vaccine or abnormal cervical screening results.
Zhangping, FujianAges 18–30 - NCT07407569RecruitingPhase 2
HPV vaccine study for women with HPV16
This study tests how HPV antibodies work in urine samples from women with HPV16 before and after they get the HPV vaccine (Gardasil 9). It helps researchers understand how the vaccine protects against HPV.
Antwerp, WilrijkAges 18–45 - NCT05027776RecruitingPhase 3
HPV vaccine study for healthy girls and young women
This trial studies whether a quadrivalent HPV vaccine is safe and helps the body build protection (immunity) against HPV. It enrolls healthy Chinese females who are not already treated for HPV-related infection.
Mianyang, SichuanAges 9–26 - NCT06513494Recruiting
Health education to boost HPV vaccine in youth
This trial tests whether active health education in schools can increase HPV vaccine coverage among students. It may help protect young people from HPV-related cancers.
Crato, CearáAges 9–14 - NCT06144229Enrolling by invitation
HPV Vaccine in Women with HIV
This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.
Denver, ColoradoAges 21–40 - NCT05625633RecruitingPhase 2/Phase 3
HPV vaccine vs placebo for stubborn skin warts
This study tests whether an HPV vaccine can help shrink or clear cutaneous (skin) warts that have not responded to prior treatments. Participants get the study vaccine or a placebo to compare results and safety.
Salt Lake City, UtahAges 18 years+ - NCT06658405RecruitingPhase 2
HPV vaccine after cervical lesion treatment
This trial tests whether an HPV vaccine (Gardasil 9) can help women over 45 who still have HPV after treatment for a high-grade cervical lesion. It compares vaccinated and unvaccinated patients to see if vaccination lowers the risk of the lesion coming back.
LilleAges 45 years+ - NCT04814446RecruitingPhase 3
Vaccine trial for stubborn warts on hands or feet
This Phase 3 trial tests a nonavalent HPV vaccine to treat long-lasting, hard-to-treat warts on the hands or feet. If you have tried standard treatments and the warts keep coming back or cause trouble, the vaccine may help your body clear the warts.
ParisAges 15 years+ - NCT06414057Recruiting
HPV study for women at higher risk in Scotland
This study looks at ways to improve cervical cancer prevention for women in Scotland who face extra challenges, such as addiction, homelessness, prison, or sex work. It includes a vaccination and screening part, plus an interview to hear your views.
EdinburghAges 25–45 - NCT05365048Recruiting
Promoting HPV vaccine visits in kids ages 9–12
This study looks at whether getting a provider recommendation helps more parents bring children ages 9–12 in for HPV vaccination. It may help increase vaccination uptake in pediatric clinics.
Pasadena, CaliforniaAges 21–70
Common questions
- Are there clinical trials studying HPV vaccine?
- Yes. Clin2 currently lists 66 recruiting studies that include HPV vaccine, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a HPV vaccine trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is HPV vaccine an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether HPV vaccine or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.